| Product Code: ETC5311269 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Ireland`s import of pulmonary/respiratory drug delivery products saw a significant increase with top exporters being Germany, UK, USA, Canada, and Areas, nes. The market concentration measured by HHI shifted from moderate to high, indicating a more consolidated market landscape. The impressive CAGR of 23.25% from 2020 to 2024 highlights the growing demand for these products in Ireland. Moreover, the remarkable growth rate of 68.68% from 2023 to 2024 underscores the accelerating pace of import activities in this sector. This data suggests a thriving market for pulmonary/respiratory drug delivery imports in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 Ireland Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2021 & 2031F |
3.6 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2021 & 2031F |
3.7 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Ireland |
4.2.2 Growing awareness about pulmonary drug delivery technologies |
4.2.3 Advancements in drug delivery devices for respiratory treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of pulmonary drug delivery devices |
4.3.2 High cost associated with development and manufacturing of advanced respiratory drug delivery systems |
5 Ireland Pulmonary/ Respiratory Drug Delivery Market Trends |
6 Ireland Pulmonary/ Respiratory Drug Delivery Market Segmentations |
6.1 Ireland Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2021-2031F |
6.2 Ireland Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2021-2031F |
6.2.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2021-2031F |
6.3 Ireland Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2021-2031F |
6.3.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2021-2031F |
6.3.4 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2021-2031F |
6.4 Ireland Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2021-2031F |
6.4.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2021-2031F |
7 Ireland Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 Ireland Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 Ireland Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Number of clinical trials involving pulmonary drug delivery technologies in Ireland |
8.2 Adoption rate of new respiratory drug delivery devices in healthcare facilities |
8.3 Investment in research and development of innovative pulmonary drug delivery solutions |
8.4 Patient satisfaction and compliance rates with pulmonary drug delivery treatments |
8.5 Number of partnerships and collaborations in the Ireland pulmonary drug delivery market |
9 Ireland Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2021 & 2031F |
9.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2021 & 2031F |
9.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |